COVID-19: Vaccines and Therapeutics

Pfizer said its COVID-19 vaccine will receive a priority review from the Food and Drug Administration, indicating that Pfizer has completed its rolling submission of its application for the vaccine’s full authorization.
A physician/chief medical social media officer at Jefferson Health posts TikTok videos to dispel myths about health care and the COVID-19 vaccine.
Trinity Health is targeting marketing and communication efforts to encourage COVID-19 vaccine confidence and administer shots to minority populations.
Alison Brisson, a member of AHA’s American Society for Health Care Engineering affiliate and director of facilities at Concord Hospital in New Hampshire, shares her reasons for getting the COVID-19 vaccine as part of AHA’s ongoing #MyWhy social media campaign to encourage vaccine confidence among…
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will convene July 22 to discuss a pair of recent issues related to COVID-19 vaccines.
Johnson & Johnson was notified that the Food and Drug Administration now will require that the company add to the label of its COVID-19 vaccine a warning of a small, increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition.
As summer moves along, the U.S. is marking a pivotal point in the pandemic. A majority of Americans — nearly 55% — now have received one COVID-19 vaccine dose, and 48% are fully vaccinated. 
 LifePoint Health combines the best of large health system resources and grassroots efforts to vaccinate hundreds of thousands of individuals across its national network.
Protecting community members by mitigating the spread of infection and feeling safe in the community were Faye Sheppard’s #MyWhy. Sheppard, a member of the American Society for Health Care Risk Management, an affiliate of the AHA, and vice chair of the Board of Directors for Cuero (Texas) Regional…